Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem … – MarketWatch (press release)
|
Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem …
MarketWatch (press release) SUNRISE, FL, Sep 23, 2013 (Marketwired via COMTEX) — Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage as well … |
